THE BEST SIDE OF ABBV-744 CLINICAL TRIAL PHASE 1 RESULTS

In Phase A, members will obtain distinct doses and schedules of oral ABBV-744 tablet to establish Safe and sound dosing routine. Further participants will be enrolled within the determined monotherapy dosign regimen. In Phase B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be offered as "increase-on" therapy. In Section C, c